|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$186,589,533 |
|
|
Indirect Value
|
$47,040,306 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$233,629,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-02-09 |
4 |
S |
$46.37 |
$4,637,340 |
D/D |
(100,000) |
1,596,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-02-09 |
4 |
OE |
$3.70 |
$369,930 |
D/D |
100,000 |
1,696,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-03-09 |
4 |
OE |
$3.70 |
$369,930 |
D/D |
100,000 |
1,734,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-03-09 |
4 |
S |
$47.44 |
$4,743,710 |
D/D |
(100,000) |
1,634,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-04-13 |
4 |
OE |
$3.70 |
$369,930 |
D/D |
100,000 |
1,734,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-04-13 |
4 |
S |
$46.32 |
$4,631,930 |
D/D |
(100,000) |
1,634,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-06-08 |
4 |
OE |
$3.70 |
$369,930 |
D/D |
100,000 |
1,734,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-06-08 |
4 |
S |
$33.41 |
$3,371,442 |
D/D |
(100,000) |
1,634,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-07-13 |
4 |
S |
$35.15 |
$3,515,000 |
D/D |
(100,000) |
1,634,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-07-13 |
4 |
OE |
$3.70 |
$369,930 |
D/D |
100,000 |
1,734,042 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2016-02-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,048,066 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2016-02-01 |
4 |
AS |
$82.98 |
$8,342,475 |
D/D |
(100,000) |
3,948,066 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2016-03-01 |
4 |
AS |
$87.79 |
$8,857,854 |
D/D |
(100,000) |
4,019,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2016-03-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,119,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-04-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,119,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-04-01 |
4 |
AS |
$91.50 |
$9,323,507 |
D/D |
(100,000) |
4,019,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-05-02 |
4 |
AS |
$87.40 |
$8,781,694 |
D/D |
(100,000) |
4,019,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-05-02 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,119,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-06-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,119,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-06-01 |
4 |
AS |
$86.72 |
$8,671,950 |
D/D |
(100,000) |
4,019,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-07-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,119,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-07-01 |
4 |
AS |
$83.36 |
$8,472,523 |
D/D |
(100,000) |
4,019,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-08-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
4,119,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-08-01 |
4 |
AS |
$80.11 |
$8,049,785 |
D/D |
(100,000) |
4,019,727 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-09-01 |
4 |
OE |
$16.40 |
$1,639,500 |
D/D |
100,000 |
3,231,096 |
0 |
- |
|
367 Records found
|
|
Page 9 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|